AlphaSniffer is commercializing a novel label-free, real time molecular analysis technology called Surface Plasmon Resonance-enhanced Common Path Interferometry (SPR-CPI) for application to medical diagnostics, microRNA analysis, and biological warfare agent detection. AlphaSniffer is focused to developing its novel and proprietary Surface Plasmon Resonance-enhanced Common Path Interferometer (SPR-CPI) system instrument platform for detection of molecular interactions so as to enhance human security, health and welfare. AlphaSnifferâs core competency is the development of analytical devices, particularly those that rely upon optoelectronics. The founders and board of directors have significant experience delivering commercial products such as the TOC analyzer to market, from idea inception through revenue generation and sale of their companies. Operational core competencies include: # Optoelectronic engineering # Signal processing # Biochemistry and bioarray engineering # Protocol development # Engineering for manufacturability
